Search
Intervention guide mhGAP for mental, neurological disorders and substance use in the level of non-specialized health care. Version 2.0
Mental, neurological and substance (MNS) disorders are very common and represent a large burden of disease and disability around the world. There remains a wide gap between the capacity of health systems and resources, between what is...
mhGAP Intervention Guide - Version 2.0 for Mental, Neurological and Substance Use Disorders in Non-Specialized Health Settings
Overview
This is the second version (2016) of the mhGAP Intervention Guide (mhGAP-IG) for mental, neurological and substance use (MNS) disorders in non-specialist health settings. It is for use by doctors, nurses, other health workers as...
Alcohol and Drugs Prevention, Treatment and Recovery: Why Invest?
Estimates show that in the UK the social and economic costs of alcohol related harm amount to £21.5bn, while harm from illicit drug use costs £10.7bn. These include costs associated with deaths, the NHS, crime and, in the case of alcohol...
The International Model of Alcohol Harms and Policies
The Canadian Institute for Substance Use Research at the University of Victoria have released The International Model of Alcohol Harms and Policies.
Comprising of a set of guidelines, methods, and tools this resource was produced with...
Identifying and Treating Patients Who Use Tobacco
'Million Hearts' is an initiative launched by the U.S. Department of Health and Human Services that aims to prevent 1 million heart attacks and strokes by promoting evidence-based intervention through communities, health systems, non-profit...
School-Based Alcohol and Drug Education and Prevention – What Works?
School-Based Alcohol and Drug Education and Prevention – What Works? is a new briefing paper published by Mentor-Adepis. It outlines several approaches that have been shown to work effectively, and issues cautions about those that have not...
‘My GP says I drink too much’: Screening and Brief Intervention
In the absence of greater obstacles to availability, widespread screening to identify and then briefly advise risky drinkers has been the great hope for improved alcohol-related public health. This major hot topic update guides you through...
Drug and Alcohol Treatment Statistics
Executive Summary
Data collected in drug treatment agencies play a prominent role in informing policy makers. Such data often represent the only information collected regularly and consistently over a certain period of time. What is even...
A Socioecological Approach to Addressing Tobacco-Related Health Disparities
Tobacco use remains the nation’s leading cause of preventable premature death, including death from cancer, and progress in reducing tobacco use and related disease and death has not been equally distributed across population groups. This...
Drug Matrix Cell A1: Interventions - Ways to Reduce the Harm
Initiates a fortnightly course on the evidence base for harm reduction and treatment in relation to illegal drugs. Comprehensively updated, the cell explores key research on interventions to reduce the harms to the user as a result of their...
Drugs, Brains and Behavior: The Science of Addiction
Since the 1930s, the response to drug addiction has moved from one that focuses on the need to punish users to another that recognises the importance of prevention and treatment approaches.
In other words, thanks to scientific advances...
EMCDDA Insights: Prevention of Substance Abuse
Prevention of Substance Abuse by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is a report that draws on evidence-based research to assess substance use prevention interventions, in terms of their ability to...
Principles of Substance Abuse Prevention for Early Childhood
The National Institute on Drug Abuse’s (NIDA) Principles of Substance Abuse Prevention for Early Childhood (2017) is a special volume that supplements the organisation’s Preventing Drug Abuse Among Children and Adolescents, released in 2003...
Tobacco Cessation Guidelines for High Risk Populations
The book “Tobacco Cessation Guidelines for High Risk Populations” is the main result of the TOB.g partnership, coordinated by the Hellenic Center for Disease Control & Prevention and consisted of four partners and specifically ENSP, CMT...
The Effectiveness of Illegal Drug Interventions
This Health Research Board document reviews evidence on the effectiveness of interventions in the areas of prevention, harm reduction and long-term recovery from addiction to illegal drugs.
It asks which interventions are effective for:
...Compilation of Evidence-Based Family Skills Training Programmes
The United Nations Office on Drugs and Crime’s (UNODC) Compilation of Evidence-Based Family Skills Training Programmes offers a treasure trove of information on such initiatives, answering key questions like:
- Who is the target group?
- W...
Standards of Knowledge for the Science of Prevention
Published by the Society for Prevention Research in 2011, Standards of Knowledge for the Science of Prevention is an important document for those working within substance use prevention.
With the aim of professionalising the field, it...
Drug Misuse and Dependence: UK Guidelines on Clinical Management
There is no more important document for doctors treating problem drug use in the UK than the so-called ‘Orange guidelines’. This major update will substantially inform judgements of what constitutes acceptable medical practice - should...
Predicting the Size and Characteristics of the Drug Treatment Population – Technical Methods
Aim and data specification
This analysis was based on monthly data from the National Drug Treatment Monitoring System (NDTMS) from December 2005 to November 2016. NDTMS is taken to be a comprehensive description of drug treatment...
Share the Knowledge: ISSUP members can post in the Knowledge Share – Sign in or become a member